CONMED Corp — Director's Dealing 2024

Jul 1, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-07-01

Reporting Person: Staves Eric (VP Corporate Controller)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	394	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options To Purchase Common Stock	$78.76	2029-03-01	Common Stock (1000)		Direct
Options To Purchase Common Stock	$97.69	2030-03-02	Common Stock (4000)		Direct
Options To Purchase Common Stock	$122.55	2031-03-01	Common Stock (4500)		Direct
Options To Purchase Common Stock	$144.55	2032-03-01	Common Stock (4750)		Direct
Options To Purchase Common Stock	$96.16	2033-03-01	Common Stock (6000)		Direct
Options To Purchase Common Stock	$79.95	2034-03-01	Common Stock (6000)		Direct
Rsus (restricted Stock Units)	$0	2032-03-07	Common Stock (250)		Direct
Rsus (restricted Stock Units)	$0	2034-07-01	Common Stock (3000)		Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.